Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards

20222023

Nov 16

Written By Guest User

Guest User

AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b

enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company